{"public_id":"cl_620592d0337eb0ef8a4ceb707e5373dd","status":"active","superseded_by_public_id":null,"corpus_id":207602966,"text":"HBIG combined with lamivudine reduced hepatitis B recurrence after liver transplantation to below 10%.","confidence":0.96,"paper":{"corpus_id":207602966,"title":"Recent advances in prevention of hepatitis B recurrence after liver transplantation.","url":"https://sah.borca.ai/papers/207602966"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_033936adff8a4ebd81defaef93e31fc7","name":"lamivudine","description":"An antiviral nucleoside analogue used against hepatitis B virus infection.","types":["antiviral drug","nucleos(t)ide analogue"],"url":"https://sah.borca.ai/concepts/co_033936adff8a4ebd81defaef93e31fc7"},{"public_id":"co_481584144058cc2c11a58772a7495438","name":"hepatitis B immunoglobulin","description":"A hepatitis B-specific immunoglobulin used as passive immunoprophylaxis.","types":["prophylactic agent","immunoglobulin"],"url":"https://sah.borca.ai/concepts/co_481584144058cc2c11a58772a7495438"},{"public_id":"co_a12ec67d050f68c4592d73078d4888a1","name":"hepatitis B recurrence after liver transplantation","description":"Return of hepatitis B infection following liver transplantation in recipients with hepatitis B virus-related disease.","types":["clinical outcome"],"url":"https://sah.borca.ai/concepts/co_a12ec67d050f68c4592d73078d4888a1"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_620592d0337eb0ef8a4ceb707e5373dd"}